This enhancement allows the user to replace current medications in a patient's treatment plan with biosimilars preferred by their insurance. It ensures the continuity of the treatment by preserving the schedule of the previously consumed drug for the newly replaced biosimilar, while historical treatment data is updated to reflect the change.
This enhancement in the Chemotherapy Manager System has been designed to facilitate the replacement of current medications in a patient's treatment plan with those preferred by their insurance, focusing on the transition from one brand to another, brand to generic drugs, or vice versa. This system ensures that when a drug is replaced due to insurance preferences, the historical data of drug consumption is preserved, reflecting the old medication on past treatment days and the new, replaced medication on future treatment days.
This enhancement in the Chemotherapy Manager has been designed to help healthcare providers manage and adjust chemotherapy treatment plans for their patients based on the changing preferences of insurance companies regarding medication. This enables the healthcare providers to easily update chemotherapy treatment plans with insurance-preferred drugs when insurance companies change their preferred drug lists.
Posted On: Dec 20, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024